
|Videos|December 14, 2015
NOAC Dosing for Obese Patients vs. Non-Obese Patients
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.
Advertisement
Katie Greenlee, PharmD, BCPS-AQ Cardiology, of the Cleveland Clinic discusses how NOAC dosing for obese patients differs from NOAC dosing for non-obese patients.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
Long-Lived Monocyte-Derived Cells Found to Support Lasting Lung Immunity Against Influenza
3
Preoperative GLP-1 Use Doesn't Change Bariatric Weight Loss Outcomes
4
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
5







































































































